Golden State Wealth Management, LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Golden State Wealth Management, LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$23,000
-51.1%
10,0000.0%0.01%
-37.5%
Q4 2021$47,000
-38.2%
10,0000.0%0.01%
-52.9%
Q3 2021$76,000
-21.6%
10,0000.0%0.02%
-19.0%
Q2 2021$97,000
+18.3%
10,0000.0%0.02%
-22.2%
Q1 2021$82,000
+20.6%
10,0000.0%0.03%
+35.0%
Q4 2020$68,000
-39.3%
10,0000.0%0.02%
-45.9%
Q3 2020$112,000
+77.8%
10,0000.0%0.04%
+131.2%
Q2 2020$63,00010,0000.02%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,623,533$22,851,0006.45%
Avoro Capital Advisors LLC 1,146,579$9,987,0003.44%
Cormorant Asset Management, LP 2,095,334$18,250,0002.18%
Healthcare Value Capital, LLC 50,000$436,0000.72%
CAPITAL MANAGEMENT ASSOCIATES /NY/ 20,000$174,0000.25%
SABBY MANAGEMENT, LLC 300,000$2,613,0000.14%
STRATEGIC INVESTMENT MANAGEMENT, LLC 20,398$177,0000.10%
Granite Investment Partners, LLC 89,622$781,0000.07%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 54,634$476,0000.06%
Trexquant Investment LP 67,929$592,0000.05%
View complete list of SORRENTO THERAPEUTICS INC shareholders